10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 364 filers reported holding 10X GENOMICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $17,016 | +153.8% | 305 | +65.8% | 0.00% | 0.0% |
| Q4 2022 | $6,705 | +235.2% | 184 | +121.7% | 0.00% | – |
| Q3 2022 | $2,000 | -60.0% | 83 | +38.3% | 0.00% | – |
| Q1 2022 | $5,000 | -75.0% | 60 | -56.2% | 0.00% | -100.0% |
| Q4 2021 | $20,000 | +11.1% | 137 | +10.5% | 0.00% | 0.0% |
| Q3 2021 | $18,000 | -25.0% | 124 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $24,000 | +33.3% | 124 | +24.0% | 0.00% | 0.0% |
| Q1 2021 | $18,000 | +28.6% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $14,000 | +16.7% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $12,000 | +33.3% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $9,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |